(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 44.67%-672.14K | 1.19%-6.08M | 48.64%-1.01M | -26.87%-2.38M | -56.10%-1.47M | 10.67%-1.21M | 32.96%-6.16M | -85.09%-1.98M | 67.04%-1.88M | -26.18%-942.41K |
Net income from continuing operations | 17.82%-2.22M | 2.56%-10.35M | 7.66%-3.38M | 20.15%-1.97M | -0.39%-2.3M | -22.52%-2.7M | 5.68%-10.62M | -48.25%-3.66M | 68.08%-2.46M | ---2.29M |
Operating gains losses | 35.94%10.04K | 12,024.96%149.62K | 47,876.85%644.03K | -1,004.86%-531.07K | 195.55%29.28K | 128.99%7.38K | 100.48%1.23K | 99.47%-1.35K | -90.33%58.69K | ---30.64K |
Depreciation and amortization | -16.55%105.43K | -4.17%477.96K | -56.08%59.36K | 39.61%178.1K | -9.30%114.16K | 14.68%126.34K | 22.26%498.77K | 10.70%135.16K | 116.47%127.57K | --125.87K |
Asset impairment expenditure | ---- | -40.10%124.7K | -40.08%124.7K | --0 | ---- | ---- | -33.76%208.16K | -29.08%208.12K | --0 | --0 |
Remuneration paid in stock | --10.37K | 230.43%219.5K | ---- | ---- | ---- | --0 | -93.47%66.43K | 31.22%66.43K | ---- | ---- |
Deferred tax | ---- | -58.42%-433.91K | ---- | ---- | ---- | ---- | -178.85%-273.89K | ---- | ---- | ---- |
Other non cashItems | 197.24%895.8K | 86.55%2.9M | -10.99%1.38M | 17,063.85%438.35K | 77,254,800.00%772.55K | 30,137,000.00%301.37K | -8.15%1.55M | 251.06%1.56M | 94.42%-2.58K | -100.00%1 |
Change In working capital | -38.67%508.58K | -65.57%829.3K | 10,481.38%366.36K | -224.47%-499.05K | -89.39%132.69K | 9.05%829.3K | 323.28%2.41M | 98.63%-3.53K | --400.93K | 267.45%1.25M |
-Change in receivables | 86.50%-19.62K | -173.96%-145.39K | ---- | ---- | ---- | 40.20%-145.39K | 809.71%196.59K | 248.22%56.88K | --125.49K | 6.65%257.34K |
-Change in inventory | -105.03%-1.33K | 118.37%26.47K | ---- | ---- | ---- | -80.90%26.47K | 54.30%-144.12K | 87.97%-32.92K | ---200.96K | -111.71%-48.81K |
-Change in prepaid assets | -74.42%8.98K | 149.36%35.09K | ---- | ---- | ---- | 223.33%35.09K | -70.02%14.07K | -50.05%34.58K | ---14.74K | 132.13%22.68K |
-Change in payables and accrued expense | -53.56%477.53K | -53.53%1.03M | ---- | ---- | ---- | 41.23%1.03M | 6,090.99%2.21M | -172.18%-329.14K | --666.19K | 170.04%1.15M |
-Change in other working capital | 137.35%43.03K | -189.30%-115.21K | ---- | ---- | ---- | -169.65%-115.21K | 116.23%129.01K | 156.62%267.07K | ---175.05K | -142.19%-128.41K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 51.99%-690.1K | 1.19%-6.08M | 48.57%-1.01M | -26.69%-2.38M | -32.49%-1.25M | -5.70%-1.44M | 32.96%-6.16M | -1.29%-1.97M | 66.20%-1.88M | ---942.41K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 182.03%235.62K | -96.83%1.21K | 0 | -314.97%-236.83K | -102.26%-13.08K | -305.83%-287.22K | 142.22%38.12K | 125.87K |
Net PPE purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | 77.18%-13.08K | -307.26%-287.22K | 137.05%38.12K | --125.87K |
Net intangibles purchas and sale | --0 | ---- | ---- | --1.21K | --0 | ---236.83K | ---- | ---- | ---- | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | 182.03%235.62K | -96.83%1.21K | --0 | -314.97%-236.83K | -102.26%-13.08K | -325.94%-287.22K | 148.95%38.12K | --125.87K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -66.68%564.15K | 1.86%6.27M | -41.27%1.44M | 21.31%2.07M | 121.20%1.07M | 11.31%1.69M | -24.06%6.16M | -67.53%2.45M | 1,154.13%1.71M | 485.73K |
Net issuance payments of debt | 26.95%678.27K | -23.36%5.28M | -47.69%1.66M | 18.58%2.02M | 118.57%1.06M | -64.87%534.27K | 117.26%6.89M | 22.50%3.18M | 1,154.13%1.71M | 66.26%485.73K |
Net common stock issuance | --0 | --726.94K | ---598.49K | --427.94K | --0 | --897.49K | --0 | ---- | ---- | --0 |
Cash dividends paid | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | --1.35K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Interest paid (cash flow from financing activities) | ---- | 96.53%-13.81K | ---- | ---- | ---- | ---- | -627.17%-397.51K | ---- | ---- | ---- |
Net other financing activities | -143.68%-114.12K | 182.53%277.14K | ---26.83K | --29.89K | --12.8K | 26,127,500.00%261.27K | ---335.79K | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -66.68%564.15K | 1.86%6.27M | -58.08%1.03M | 45.41%2.48M | 121.20%1.07M | 11.31%1.69M | -24.06%6.16M | 48.75%2.45M | -70.21%1.71M | --485.73K |
Net cash flow | ||||||||||
Beginning cash position | 146.88%319.95K | -6.59%129.6K | 113.07%15.13K | -232.70%-25.61K | -57.58%148.52K | 64.58%129.6K | -78.24%138.74K | -136.49%-115.73K | -92.78%19.3K | 30.91%350.11K |
Current changes in cash | -765.43%-125.95K | 2,272.55%191.99K | 67.12%306.46K | 130.68%40.74K | 47.36%-174.13K | -93.03%18.93K | 98.21%-8.84K | 203.94%183.38K | -249.12%-132.78K | ---330.81K |
Effect of exchange rate changes | --0 | -427.83%-1.63K | -183.78%-1.63K | 100.22%5 | ---2 | ---2 | 95.12%-309 | 199.29%1.95K | 66.60%-2.26K | --0 |
End cash Position | 30.63%194.01K | 146.88%319.95K | 146.88%319.95K | 113.07%15.13K | -232.70%-25.61K | -57.58%148.52K | -6.59%129.6K | -6.59%129.6K | -136.49%-115.73K | -92.78%19.3K |
Free cash from | 58.78%-690.1K | 1.40%-6.08M | 60.77%-779.29K | -26.63%-2.38M | -32.49%-1.25M | -23.12%-1.67M | 34.46%-6.17M | -0.22%-1.99M | 66.81%-1.88M | ---942.41K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data